Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Molecular Biosystems
|
June 23, 2010
Peptide modified nanocarriers for selective targeting of bombesin receptors
Antonella Accardo, Rosalba Mansi, Anna Morisco, et al.
Journal of Medicinal Chemistry
|
April 5, 2011
Highly improved metabolic stability and pharmacokinetics of indium-111-DOTA-gastrin conjugates for targeting of the gastrin receptor
Petra Kolenc-Peitl, Rosalba Mansi, MariaLuisa Tamma, et al.
Frontiers in Nuclear Medicine
|
October 28, 2024
Copper-61 is an advantageous alternative to gallium-68 for PET imaging of somatostatin receptor-expressing tumors: a head-to-head comparative preclinical study
Tais Basaco Bernabeu, Rosalba Mansi, Luigi Del Pozzo, et al.
Journal of Medicinal Chemistry
|
March 9, 2018
New Gastrin Releasing Peptide Receptor-Directed [<sup>99m</sup>Tc]Demobesin 1 Mimics: Synthesis and Comparative Evaluation
Berthold A Nock, David Charalambidis, Werner Sallegger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 18, 2011
PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference
Melpomeni Fani, Luigi Del Pozzo, Keelara Abiraj, et al.
Theranostics
|
March 1, 2014
Positron emission tomography (PET) imaging of prostate cancer with a gastrin releasing peptide receptor antagonist--from mice to men
Gesche Wieser, Rosalba Mansi, Anca L Grosu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 14, 2018
Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog <sup>177</sup>Lu-DOTA-PP-F11N: Does the Use of Protease Inhibitors Further Improve In Vivo Distribution?
Alexander W Sauter, Rosalba Mansi, Ulrich Hassiepen, et al.
Journal of Drug Targeting
|
November 22, 2012
Bombesin peptide antagonist for target-selective delivery of liposomal doxorubicin on cancer cells
Antonella Accardo, Rosalba Mansi, Giuseppina Salzano, et al.
Pharmaceuticals (Basel, Switzerland)
|
December 31, 2020
Selection of the First <sup>99m</sup>Tc-Labelled Somatostatin Receptor Subtype 2 Antagonist for Clinical Translation-Preclinical Assessment of Two Optimized Candidates
Melpomeni Fani, Viktoria Weingaertner, Petra Kolenc Peitl, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 19, 2017
Diagnosis of recurrent prostate cancer with PET/CT imaging using the gastrin-releasing peptide receptor antagonist <sup>68</sup>Ga-RM2: Preliminary results in patients with negative or inconclusive [<sup>18</sup>F]Fluoroethylcholine-PET/CT
Gesche Wieser, Ilinca Popp, H Christian Rischke, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Molecular Biosystems
|
June 23, 2010
Peptide modified nanocarriers for selective targeting of bombesin receptors
Antonella Accardo, Rosalba Mansi, Anna Morisco, et al.
Journal of Medicinal Chemistry
|
April 5, 2011
Highly improved metabolic stability and pharmacokinetics of indium-111-DOTA-gastrin conjugates for targeting of the gastrin receptor
Petra Kolenc-Peitl, Rosalba Mansi, MariaLuisa Tamma, et al.
Frontiers in Nuclear Medicine
|
October 28, 2024
Copper-61 is an advantageous alternative to gallium-68 for PET imaging of somatostatin receptor-expressing tumors: a head-to-head comparative preclinical study
Tais Basaco Bernabeu, Rosalba Mansi, Luigi Del Pozzo, et al.
Journal of Medicinal Chemistry
|
March 9, 2018
New Gastrin Releasing Peptide Receptor-Directed [<sup>99m</sup>Tc]Demobesin 1 Mimics: Synthesis and Comparative Evaluation
Berthold A Nock, David Charalambidis, Werner Sallegger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 18, 2011
PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference
Melpomeni Fani, Luigi Del Pozzo, Keelara Abiraj, et al.
Theranostics
|
March 1, 2014
Positron emission tomography (PET) imaging of prostate cancer with a gastrin releasing peptide receptor antagonist--from mice to men
Gesche Wieser, Rosalba Mansi, Anca L Grosu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 14, 2018
Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog <sup>177</sup>Lu-DOTA-PP-F11N: Does the Use of Protease Inhibitors Further Improve In Vivo Distribution?
Alexander W Sauter, Rosalba Mansi, Ulrich Hassiepen, et al.
Journal of Drug Targeting
|
November 22, 2012
Bombesin peptide antagonist for target-selective delivery of liposomal doxorubicin on cancer cells
Antonella Accardo, Rosalba Mansi, Giuseppina Salzano, et al.
Pharmaceuticals (Basel, Switzerland)
|
December 31, 2020
Selection of the First <sup>99m</sup>Tc-Labelled Somatostatin Receptor Subtype 2 Antagonist for Clinical Translation-Preclinical Assessment of Two Optimized Candidates
Melpomeni Fani, Viktoria Weingaertner, Petra Kolenc Peitl, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 19, 2017
Diagnosis of recurrent prostate cancer with PET/CT imaging using the gastrin-releasing peptide receptor antagonist <sup>68</sup>Ga-RM2: Preliminary results in patients with negative or inconclusive [<sup>18</sup>F]Fluoroethylcholine-PET/CT
Gesche Wieser, Ilinca Popp, H Christian Rischke, et al.
Page
of 6